Stericycle (NASDAQ:SRCL) Receives New Coverage from Analysts at StockNews.com

Research analysts at StockNews.com assumed coverage on shares of Stericycle (NASDAQ:SRCL) in a research note issued on Saturday. The brokerage set a “hold” rating on the business services provider’s stock.

Other research analysts have also recently issued research reports about the company. Keefe, Bruyette & Woods upped their price target on Stericycle from $135.00 to $142.00 and gave the company an “outperform” rating in a report on Tuesday, June 4th. Truist Financial boosted their target price on shares of Stericycle from $50.00 to $62.00 and gave the company a “hold” rating in a research note on Tuesday, June 4th. Royal Bank of Canada reissued a “sector perform” rating and set a $62.00 target price (down from $69.00) on shares of Stericycle in a research note on Tuesday, June 4th. Wells Fargo & Company boosted their target price on shares of Stericycle from $40.00 to $48.00 and gave the company an “underweight” rating in a research note on Friday, March 1st. Finally, Robert W. Baird cut their target price on shares of Stericycle from $62.00 to $55.00 and set a “neutral” rating on the stock in a research note on Friday, April 26th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $74.00.

Stericycle Price Performance

Shares of NASDAQ:SRCL opened at $58.13 on Friday. Stericycle has a 12 month low of $37.78 and a 12 month high of $59.45. The stock has a market cap of $5.39 billion, a price-to-earnings ratio of -264.23, a PEG ratio of 3.10 and a beta of 1.08. The stock’s 50 day moving average price is $51.77 and its 200 day moving average price is $50.77. The company has a debt-to-equity ratio of 0.55, a current ratio of 1.11 and a quick ratio of 1.11.

Stericycle (NASDAQ:SRCL) last posted its quarterly earnings results on Thursday, April 25th. The business services provider reported $0.57 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.54 by $0.03. The company had revenue of $664.90 million for the quarter, compared to analysts’ expectations of $676.42 million. Stericycle had a positive return on equity of 7.31% and a negative net margin of 0.74%. The firm’s revenue was down 2.8% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.49 earnings per share. Equities research analysts anticipate that Stericycle will post 2.32 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Stericycle

Institutional investors and hedge funds have recently modified their holdings of the stock. Clearstead Trust LLC purchased a new position in shares of Stericycle during the 1st quarter valued at $25,000. Principal Securities Inc. bought a new stake in Stericycle in the fourth quarter worth $41,000. GAMMA Investing LLC boosted its holdings in Stericycle by 170.9% in the first quarter. GAMMA Investing LLC now owns 818 shares of the business services provider’s stock worth $43,000 after purchasing an additional 516 shares in the last quarter. TFO Wealth Partners LLC lifted its position in Stericycle by 22,325.0% during the 4th quarter. TFO Wealth Partners LLC now owns 897 shares of the business services provider’s stock worth $44,000 after acquiring an additional 893 shares during the last quarter. Finally, Headlands Technologies LLC acquired a new position in Stericycle during the 1st quarter worth $44,000. 98.82% of the stock is currently owned by hedge funds and other institutional investors.

Stericycle Company Profile

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.